Lack of Pharmacokinetic Interaction between the Oral Anti-Influenza Prodrug Oseltamivir and Aspirin

AUTOR(ES)

Oo, Charles

FONTE

American Society for Microbiology

RESUMO

Twelve volunteers completed a two-sequence, three-way crossover study of a single 900-mg aspirin dose and multiple doses of 75 mg of oseltamivir in the absence and presence of 900 mg of aspirin. The plasma and urine results demonstrated no pharmacokinetic interaction between oseltamivir and aspirin.

Documentos Relacionados

• Comparison of the Anti-Influenza Virus Activity of RWJ-270201 with Those of Oseltamivir and Zanamivir
• Mechanism of Action of Anti-Influenza Benzamidine Derivatives
• The Anti-Influenza Virus Drug Rimantadine Has Trypanocidal Activity
• The molecular basis of the specific anti-influenza action of amantadine.
• Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.